Carbidopa Tablets, 25 mg (Alvogen Inc.)
Welcome to the PulseAid listing for the Carbidopa Tablets, 25 mg drug offered from Alvogen Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alvogen Inc. |
| NON-PROPRIETARY NAME: | Carbidopa Tablets, 25 mg |
| SUBSTANCE NAME: | CARBIDOPA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-01-26 |
| END MARKETING DATE: | 0000-00-00 |
Carbidopa Tablets, 25 mg HUMAN PRESCRIPTION DRUG Details:
| Item Description | Carbidopa Tablets, 25 mg from Alvogen Inc. |
| LABELER NAME: | Alvogen Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25(mg/1) |
| START MARKETING DATE: | 2016-01-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47781-332_5d1077f9-2b99-add8-55b9-e3b30b736e5a |
| PRODUCT NDC: | 47781-332 |
| APPLICATION NUMBER: | ANDA204291 |
Other CARBIDOPA Pharmaceutical Manufacturers / Labelers:
